НовостиBenzingaJefferies Initiates Coverage On Iambic Therapeutics with Buy Rating, Announces Price Target of $35 Jefferies Initiates Coverage On Iambic Therapeutics with Buy Rating, Announces Price Target of $35 Benzinga 2026.11.10 14:19 (GMT+0) Открыть на Benzinga Другие новости